The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of A2a Pharmaceuticals, Inc. since 2021.
This trader's CIK number is 1859061.
At the time of last reporting, A2a Pharmaceuticals, Inc. was the 10% Owner of Biomea Fusion, Inc.. (stock ticker symbol BMEA).
Also see all insider trading activities at Biomea Fusion, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | BMEA | 0 | $0 | 925,000 | $30,022,650 | 0 | $0 |
| 2022 | BMEA | 30,684 | $425,648 | 69,316 | $796,094 | 0 | $0 |
| 2021 | BMEA | 34,658 | $379,851 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-06-01 | BMEA | Sale | 50,000 | 34.56 | 1,728,150 |
| 2023-05-31 | BMEA | Sale | 75,000 | 33.81 | 2,535,750 |
| 2023-06-01 | BMEA | Sale | 50,000 | 34.56 | 1,728,150 |
| 2023-05-31 | BMEA | Sale | 75,000 | 33.81 | 2,535,750 |
| 2023-05-12 | BMEA | Sale | 25,000 | 33.84 | 846,000 |
| 2023-05-09 | BMEA | Sale | 150,000 | 34.51 | 5,175,750 |
| 2023-05-08 | BMEA | Sale | 100,000 | 33.99 | 3,399,300 |
| 2023-04-20 | BMEA | Sale | 200,000 | 29.12 | 5,823,800 |
| 2023-03-31 | BMEA | Sale | 200,000 | 31.25 | 6,250,000 |
| 2022-08-16 | BMEA | Buy | 30,684 | 13.87 | 425,648 |
| 2022-07-21 | BMEA | Sale | 34,658 | 11.21 | 388,516 |
| 2022-06-24 | BMEA | Sale | 34,658 | 11.76 | 407,578 |
| 2021-09-17 | BMEA | Buy | 34,658 | 10.96 | 379,851 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by A2a Pharmaceuticals, Inc. (10% Owner of Biomea Fusion, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.